Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer-Reference-Cited by-同舟云学术

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer

Published:2017-11-02 Issue:11 Volume:12 Page:e0186847
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Geng Xiaocong,Liu Yueyang,Diersch Sandra,Kotzsch Matthias,Grill Sabine,Weichert Wilko,Kiechle Marion,Magdolen Viktor^ORCID,Dorn Julia

Funder

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features;J Prat;Virchows Arch,2012

2. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research;E Kipps;Nat Rev Cancer,2013

3. OVSCORE—a validated score to identify ovarian cancer patients not suitable for primary surgery;J Dorn;Oncol Lett,2015

4. The kallikrein-related peptidase family: Dysregulation and functions during cancer progression;T Kryza;Biochimie,2016

5. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker;GM Yousef;Cancer Res,2001

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midkine: A Cancer Biomarker Candidate and Innovative Therapeutic Approaches;European Journal of Breast Health;2024-07-01

2. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

3. Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer;Journal of Computational Biology;2023-04-01

4. A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression;Life;2022-09-28

5. The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine;International Journal of Molecular Sciences;2022-09-01